Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.
 

Notice of Funding Opportunities

Title Announcement Number Activity Code Clinical Trials Status Expiration Date Program Official
HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices RFA-NS-23-003 (RM1 Clinical Trial Optional) RM1 Clinical Trial Optional 06/10/2025
Mechanisms that Impact Cancer Risk after Bariatric Surgery PAR-21-331 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 09/08/2024 Edward Sauter, M.D., Ph.D.
HEAL Initiative: Understanding Individual Differences in Human Pain Conditions RFA-NS-24-021 (R01 - Clinical Trial Optional) R01 Clinical Trial Optional 02/07/2025 Rachel Altshuler, Ph.D.
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics PAR-23-279 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 01/08/2027 Edward Sauter, M.D., Ph.D.
Pancreatic Cancer Detection Consortium: Research Units PAR-21-334 (U01 Clinical Trial Optional) U01 Clinical Trial Optional 06/12/2024 Matthew Young, Ph.D.
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies PAR-21-329 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 11/06/2024 Rachel Altshuler, Ph.D.
Biology of Bladder Cancer PAR-22-218 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 09/08/2025
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers PAR-23-287 (K99/R00 - Independent Clinical Trial Required) R00, K99 Clinical Trial Required 10/15/2026 Jessica Faupel-Badger, Ph.D., M.P.H.
Cancer Prevention and Control Clinical Trials Grant Program PAR-24-072 (R01 Clinical Trial Required) R01 Clinical Trial Required 01/08/2027 Brandy Heckman-Stoddard, Ph.D., M.P.H.
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis PAR-24-085 (R01 Clinical Trial Required) R01 Clinical Trial Required 01/08/2027 Brandy Heckman-Stoddard, Ph.D., M.P.H.